A novel splice-site variant of the LAMB3 gene is associated with junctional epidermolysis bullosa

Eur J Dermatol. 2022 Sep 1;32(5):632-636. doi: 10.1684/ejd.2022.4318.

Abstract

Background: Junctional epidermolysis bullosa (JEB) is a rare inherited genetic disorder in which pathogenic mutations are mostly located within exons of the associated genes. This report describes a novel variant located at a splice site.

Objectives: To confirm the diagnosis of the JEB family and identify the pathogenic variant.

Materials & methods: We collected clinical data and DNA from the members of the family. Whole-exome sequencing (WES) and Sanger sequencing were used to detect gene variants. The pMINI minigene system was used to design in vitro experiments, to confirm the pathogenic variants.

Results: A novel splice-site variant (c.629-12T>G) of the LAMB3 gene was detected in all patients and was shown to be a pathogenic variant.

Conclusion: The diagnosis of JEB should depend on gene sequencing, and variants at splice sites may also cause the disease.

Keywords: splice-site variant; junctional epidermolysis bullosa; LAMB3 gene; minigene.

MeSH terms

  • Epidermolysis Bullosa, Junctional* / genetics
  • Exome Sequencing
  • Exons
  • Humans
  • Mutation
  • Rare Diseases